uniQure N.V. (QURE) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Uniqure N.v..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.479 Thank you for standing by. My name is Liz and I'll be your conference operator today. 00:00:04.479 -- 00:00:09.788 At this time, I would like to welcome everyone to the Unicure first quarter 2026 earnings 00:00:09.788 -- 00:00:14.757 call. All lines have been placed on mute to prevent any background noise. 00:00:14.757 -- 00:00:18.003 After the speaker's remarks, there will be a question and answer session. 00:00:18.003 -- 00:00:22.387 If you would like to ask a question during this time, simply press star followed by the 00:00:22.387 -- 00:00:26.872 number one on your telephone keypad. If you would like to withdraw your question, press 00:00:26.872 -- 00:00:32.258 star one again. Thank you. I would now like to turn the call over to Kiara Russo, Senior 00:00:32.258 -- 00:00:36.920 Director of Investor Relations. Please go ahead. 00:00:37.823 -- 00:00:42.989 Good morning, and thank you for joining us for UNICARE's first quarter of 2026 earnings 00:00:42.989 -- 00:00:47.546 call. Earlier this morning, Unicure released its financial results for the first quarter 00:00:47.546 -- 00:00:52.491 of 2026, and our press release is available on the Investors and Media section of our 00:00:52.491 -- 00:00:55.334 website at unicure.com. 00:00:55.334 -- 00:01:00.099 Our 10Q was also filed with the SEC earlier today. 00:01:00.099 -- 00:01:05.024 Joining me on the call this morning are Matt Kapisa, Chief Executive Officer, Dr. 00:01:05.024 -- 00:01:10.190 Waleed Abisab, Chief Medical Officer, Kylie O'Keefe, Chief Customer and Strategy 00:01:10.190 -- 00:01:13.792 Officer, and Christian Klempt, Chief Financial Officer. 00:01:13.792 -- 00:01:18.098 After our formal remarks, we'll open the call up for Q&A. 00:01:18.098 -- 00:01:22.104 Before we begin...